Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients

Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients

Daniel Aletaha,1 Sonya J Snedecor,2 Varun Ektare,2 Mei Xue,2 Yanjun Bao,3 Vishvas Garg3 1Division of Rheumatology, Department of Internal Medicine, Medical University of Vienna, Vienna, Austria; 2Pharmerit International, Bethesda, MD, 3AbbVie Inc., North Chicago, IL, USA Objective: To compare the re...

Full description

Bibliographic Details
Main Authors: Aletaha D, Snedecor SJ, Ektare V, Xue M, Bao Y, Garg V
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
rheumatoid arthritis
anti-TNF
economic analysis
dose taper
treatment withdrawal
Online Access:https://www.dovepress.com/clinical-and-economic-analysis-of-outcomes-of-dose-tapering-or-withdra-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/clinical-and-economic-analysis-of-outcomes-of-dose-tapering-or-withdra-peer-reviewed-article-CEOR

Similar Items